Pediatric Neurology
Volume 33, Issue 4 , Pages 227-234 , October 2005

Aggravation of Epilepsy By Antiepileptic Drugs

  • Mona Sazgar, MD

      Affiliations

    • State University of New York at Buffalo, The Jacobs Neurological Institute, Buffalo, New York
    • Corresponding Author InformationCommunications should be addressed to: Dr. Bourgeois; Harvard Medical School, Children’s Hospital Boston; Division of Epilepsy and Clinical Neurophysiology, HU-2; 300 Longwood Avenue; Boston, MA 02115.
    • ,
  • Blaise F.D. Bourgeois, MD

      Affiliations

    • Harvard Medical School, Children’s Hospital Boston, Division of Epilepsy and Clinical Neurophysiology, Boston, Massachusetts

Received 11 November 2004 ,Accepted 14 March 2005.

References 

  1. Perucca E , Gram L , Avanzini G , Dulac O . Antiepileptic drugs as a cause of worsening seizures . Epilepsia . 1998;39:5–17
  2. Guerrini R , Belmonte A , Genton P . Antiepileptic drug-induced worsening of seizures in children . Epilepsia . 1998;39(Suppl. 3):S2–S10
  3. Genton P , McMenamin J . Aggravation of seizures by antiepileptic drugs (What to do in clinical practice) . Epilepsia . 1998;39(Suppl. 3):S26–S29
  4. Genton P . When antiepileptic drugs aggravate epilepsy . Brain Dev . 2000;22:75–80
  5. Lerman P . Seizures induced or aggravated by anticonvulsants . Epilepsia . 1986;27:706–710
  6. Bourgeois BF . Reducing overtreatment . Epilepsy Res . 2002;52:53–60
  7. Hosford DA , Clark S , Cao Z , et al.   The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice . Science . 1992;257:398–401
  8. Bittiger H , Froestl W , Mickel SJ , Olpe HR . GABAB receptor antagonists (From synthesis to therapeutic applications) . TIPS . 1993;14:391–394
  9. Karlsson G , Kolb C , Hausdorf A , Portet C , Schmutz M , Olpe HR . GABAB receptors in various in vitro and in vivo models of epilepsy (A study with the GABAB receptor blocker CGP-35348) . Neuroscience . 1992;47:63–68
  10. Vergnes M , Marescaux C , Micheletti G , Depaulis A , Rumbach L , Warter JM . Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit-mal-like epilepsy . Neurosci Lett . 1984;44:91–94
  11. Geladse T , Djibladse M , Toise O , Nicolaishvili R . Activation of electroclinical events by carbamazepine therapy . Epilepsia . 1996;37(Suppl. 4):66
  12. Rodin EA , Rim CS , Rennick PM . The effects of Tegretol on the EEG . Electroencephalogr Clin Neurophysiol . 1976;37:329
  13. Steriade M , Curro Dossi R , Nunez A . Network modulation of a slow intrinsic oscillation of cat thalamocortical neurons implicated in sleep delta waves (Cortically-induced synchronization and brain stem cholinergic suppression) . J Neurosci . 1991;11:3200–3217
  14. Curro Dossi R , Nunez A , Steriade M . Electrophysiology of a low (0.5-4 HZ) intrinsic oscillation of cat thalamocortical neurons in vivo . J Physiol . 1992;447:215–234
  15. Troupin AS , Ojemann LM . Paradoxical intoxication (A complication of anticonvulsant administration) . Epilepsia . 1975;16:753–758
  16. Vallarta JM , Bell DB , Reichert A . Progressive encephalopathy due to chronic hydantoin intoxication . Am J Did Child . 1974;128:27–34
  17. Osorio I , Burnstine R , Remler B , Manon-Espallat R , Reed RC . Phenytoin-induced seizures (A paradoxical effect at toxic concentrations in epileptic patients) . Epilepsia . 1989;30:230–240
  18. Guerrini R , Belmonte A , Parmeggiani L , Perucca E . Myoclonic status epilepticus following high-dosage lamotrigine therapy . Brain Dev . 1999;21:420–424
  19. Janszky J , Rasonyi G , Halasz P , et al.   Disabling erratic myoclonus during lamotrigine therapy with high serum level (Report of two cases) . Clin Neuropharmacol . 2000;23:86–89
  20. Snead OC , Hosey LC . Exacerbation of seizures in children by carbamazepine . N Engl J Med . 1985;313:916–921
  21. Guerrini R , Belmonte A , Strumia S , Hirsch E . Exacerbation of epileptic negative myoclonus by carbamazepine or phenobarbital in children with atypical benign rolandic epilepsy . Epilepsia . 1995;36(Suppl. 3):S65
  22. Caraballo R , Fontana E , Michelizza B . Carbamazepina, “assenze atipiche,” “Crisi atoniche” e stato di P.O.continua del sonno (P.O.C.S.) Boll Lega It Epil . 1989;66/67:379–381
  23. Horn CS , Ater SB , Hurst DL . Carbamazepine-exacerbated epilepsy in children and adolescents . Pediatr Neurol . 1986;2:340–345
  24. Dhuna A , Pascual-Leone A , Talwar D . Exacerbation of partial seizures and onset of nonepileptic myoclonus with carbamazepine . Epilepsia . 1991;32:275–278
  25. Parmeggiani A , Fraticelli E , Rossi PG . Exacerbation of epileptic seizures by carbamazepine (Report of 10 cases) . Seizure . 1998;7:479–483
  26. Gansaeuer M , Alsaadi TM . Carbamazepine-induced seizures (A case report and review of the literature) . Clin Electroencephalogr . 2002;33:174–177
  27. Kochen S , Giagante B , Oddo S . Spike-and-wave complexes and seizure exacerbation caused by carbamazepine . Eur J Neurol . 2002;9:41–47
  28. Prasad AN , Stefanelli M , Nagarajan L . Seizure exacerbation and developmental regression with carbamazepine . Can J Neurol Sci . 1998;25:287–294
  29. Talwar D , Arora MS , Sher PK . EEG changes and seizure exacerbation in young children treated with carbamazepine . Epilepsia . 1994;35:1154–1159
  30. Shields WD , Saslow E . Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children . Neurology . 1983;33:1487–1489
  31. So EL , Ruggles KH , Cascino GD , Ahmann PA , Weatherford KW . Seizure exacerbation and status epilepticus related to carbamazepine-10,11-epoxide . Ann Neurol . 1994;35:743–746
  32. Genton P , Gelisse P , Thomas P , Dravet C . Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? . Neurology . 2000;5:1106–1109
  33. Biraben A , Allain H , Scarabin JM , Schuck S , Edan G . Exacerbation of juvenile myoclonic epilepsy with lamotrigine . Neurology . 2000;55:1758
  34. Carrazana EJ , Wheeler SD . Exacerbation of juvenile myoclonic epilepsy with lamotrigine . Neurology . 2001;56:1424–1425
  35. Lerman-Sagie T , Watemberg N , Kramer U , Shahar E , Lerman P . Absence seizures aggravated by valproic acid . Epilepsia . 2001;42:941–943
  36. Hirsch E , Genton P . Antiepileptic drug-induced pharmacodynamic aggravation of seizures (Does valproate have a lower potential?) . CNS Drugs . 2003;17:633–640
  37. Tassinari CA , Dravet C , Roger J , Cano JP , Gastaut H . Tonic status epilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome . Epilepsia . 1972;13:421–435
  38. Tassinari CA , Gastaut H , Dravet C , Roger J . A paradoxical effect (Status epilepticus induced by benzodiazepines (Valium and Mogadon)) . Electroencephalogr Clin Neurophysiol . 1971;31:182
  39. Prior PF , Maclaine GN , Scott DF , Laurance BM . Tonic status epilepticus precipitated by intravenous diazepam in a child with petit mal status . Epilepsia . 1971;13:467–472
  40. Bittencourt PR , Richens A . Anticonvulsant-induced status epilepticus in Lennox-Gastaut syndrome . Epilepsia . 1991;22:129–134
  41. DiMario FJ , Clancy RR . Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures . Ped Neurol . 1988;4:249–251
  42. Papini M , Pasquinelli A , Armellini M , Orlandi D . Alertness and incidence of seizures in patients with Lennox-Gastaut syndrome . Epilepsia . 1984;25:161–167
  43. Engel J . Inhibitory mechanisms of epileptic seizure generation . Adv Neurol . 1995;67:157–171
  44. Liporace JD , Sperling MR , Dichter MA . Absence seizures and carbamazepine in adults . Epilepsia . 1994;35:1026–1028
  45. Gelisse P , Genton P , Kuate C , Pesenti A , Baldy-Moulinier M , Crespel A . Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies . Epilepsia . 2004;45:282–286
  46. Patel H , Crichton JV . The neurologic hazards of diphenylhydantoin in childhood . J Pediatr . 1968;73:676–684
  47. Hamano S , Mochizuki M , Morikawa T . Phenobarbital-induced atypical absence seizures in benign childhood epilepsy with centrotemporal spikes . Seizure . 2002;11:201–204
  48. Guerrini R , Dravet C , Genton P , Belmonte A , Kaminska A , Dulac O . Lamotrigine and seizure aggravation in severe myoclonic epilepsy . Epilepsia . 1998;39:508–512
  49. Cerminara C , Montanaro ML , Curatolo P , Seri S . Lamotrigine-induced seizure aggravation and negative myoclonus in idiopathic rolandic epilepsy . Neurology . 2004;63:373–375
  50. Prats JM , Garaizar C , Garcia-Nieto ML , Madoz P . Antiepileptic drugs and atypical evolution of idiopathic partial epilepsy . Pediatr Neurol . 1998;18:402–406
  51. Corda D , Gelisse P , Genton P , Dravet C , Baldy-Moulinier M . Incidence of drug-induced aggravation in benign epilepsy with centrotemporal spikes . Epilepsia . 2001;42:754–759
  52. Schapel G , Chadwick D . Tiagabine and non-convulsive status epilepticus . Seizure . 1996;5:153–156
  53. Ettinger AB , Bernal OG , Andriola MR , et al.   Two cases of nonconvulsive status epilepticus in association with tiagabine therapy . Epilepsia . 1999;40:1159–1162
  54. Imperiale D , Pignatta P , Cerrato P , Montalenti E , Ravetti C , Benna P . Nonconvulsive status epilepticus due to a de novo contralateral focus during tiagabine adjunctive therapy . Seizure . 2003;12:319–322
  55. Piccinelli P , Borgatti R , Perucca E , Tofani A , Donati G , Balottin U . Frontal nonconvulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria . Epilepsia . 2000;41:1485–1488
  56. Lortie A , Chiron C , Mumford J , Dulac O . The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin . Neurology . 1993;43(11 Suppl. 5):S24–S27
  57. Panayiotopoulos CP , Agathonikou A , Sharoqi IA , Parker AP . Vigabatrin aggravates absences and absence status . Neurology . 1997;49:1467
  58. Cocito L , Primavera A . Vigabatrin aggravates absences and absence status . Neurology . 1998;51:1519–1520
  59. Asconape J , Diedrich A , DellaBadia J . Gabapentin-associated myoclonus . Neurology . 1995;45(Suppl. 4):A249–A250
  60. Asconape J , Diedrich A , DellaBadia J . Myoclonus associated with the use of gabapentin . Epilepsia . 2000;41:479–481
  61. Scheyer RD , Assaf BA , Spencer SS , Mattson RH . Gabapentin related myoclonus . Epilepsia . 1996;37(Suppl. 5):203
  62. Vossler DG . Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin . Neurology . 1996;46:852–853
  63. Bauer J . Seizure-inducing effects of antiepileptic drugs (A review) . Acta Neurol Scand . 1996;94:367–377
  64. Marescaux C , Warter JM , Micheletti G , Rumbach L , Coquillat G , Kurtz D . Stuporous episodes during treatment with sodium valproate (Report of seven cases) . Epilepsia . 1982;23:297–305
  65. Sackellares JC , Lee SI , Dreifuss FE . Stupor following administration of valproic acid to patients receiving other antiepileptic drugs . Epilepsia . 1979;20:697–703
  66. Völzke E , Doose H . Dipropylacetate (Depakine, Ergenyl) in the treatment of epilepsy . Epilepsia . 1973;14:185–193
  67. Bellman MH , Ross EM . Side effects of sodium valproate . Br Med J . 1977;274:1662
  68. Coulter DL , Allen RJ . Secondary hyperammonemia (A possible mechanism for valproate encephalopathy) . Lancet . 1980;1:1310–1311
  69. Coulter DL , Allen RJ . Hyperammonemia with valproic acid therapy . J Pediatr . 1981;99:317–319
  70. Rawat S , Borkowski WJ , Swick HM . Valproic acid and secondary hyperammonemia . Neurology . 1981;31:1173–1174
  71. Kifune A , Kubota F , Shibata N , Akata T , Kikuchi S . Valproic acid-induced hyperammonemic encephalopathy with triphasic waves . Epilepsia . 2000;41:909–912
  72. Chen WT , Yen DJ , Yu HY , Liao KK . Valproate-induced encephalopathy . Zhonghua Yi Xue Za Zhi (Taipei) . 2001;64:474–478
  73. Triggs WJ , Gilmore RL , Millington DS , Cibula J , Bunch TS , Harman E . Valproate-associated carnitine deficiency and malignant cerebral edema in the absence of hepatic failure . Int J Clin Pharmacol Ther . 1997;35:353–356
  74. Vossler DG , Wilensky AJ , Cawthon DF , et al.   Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy . Epilepsia . 2002;43:154–159
  75. Verrotti A , Trotta D , Morgese G , Chiarelli F . Valproate-induced hyperammonemic encephalopathy . Metab Brain Dis . 2002;17:367–373
  76. Ziyeh S , Thiel T , Spreer J , Klisch J , Schumacher M . Valproate-induced encephalopathy (Assessment with MR imaging and 1H MR spectroscopy) . Epilepsia . 2002;43:1101–1105
  77. Rai PV . Acute intoxication during a combined treatment of sodium valproate and phenobarbitone . In:  Meinardi H ,  Rowan AJ editor. Advances in epileptology . Amsterdam: Swets Zertlinger; 1978;p. 366–369
  78. Bruni J , Wilder J . Valproic acid (Review of a new antiepileptic drug) . Arch Neurol . 1979;36:393–398
  79. Murphy JV , Marquardt K . Asymptomatic hyperammonemia in patients receiving valproic acid . Arch Neurol . 1982;39:591–593
  80. Rottach KG , Weiss-Brummer J , Wieland U , Schmauss M . Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy . Nervenarzt . 2000;71:401–403
  81. Reif A , Leonhard C , Mossner R , Lesch KP , Fallgatter AJ . Encephalopathy and myoclonus triggered by valproic acid . Prog Neuropsychopharmacol Biol Psychiatry . 2004;28:1061–1063
  82. Sobaniec-Lotowska ME , Sobaniec W . Morphological features of encephalopathy after chronic treatment of the antiepileptic drug valproate to rats (A transmission electron microscopic study of capillaries in the cerebellar cortex) . Exp Toxicol Pathol . 1996;48:65–75
  83. Sobaniec-Lotowska ME . Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal . Int J Exp Pathol . 2003;84:115–125
  84. Salke-Kellermann A , Baier H , Rambeck B , Boenigk HE , Wolf P . Acute encephalopathy with vigabatrin . Lancet . 1993;342:185
  85. Hamer HM , Knake S , Schomburg U , Rosenow F . Valproate-induced hyperammonemic encephalopathy in the presence of topiramate . Neurology . 2000;54:230–232
  86. Longin E , Teich M , Koelfen W , Konig S . Topiramate enhances the risk of valproate-associated side effects in three children . Epilepsia . 2002;43:451–454
  87. Solomon GE . Valproate-induced hyperammonemic encephalopathy in the presence of topiramate . Neurology . 2000;55:606
  88. Latour P , Biraben R , Polard E , et al.   Drug induced encephalopathy in six epileptic patients (Topiramate? valproate? or both?) . Hum Psychopharmacol Clin Exp . 2004;19:193–203
  89. Steinhoff BJ , Stodieck SR . Temporary abolition of seizure activity by flumazenil in a case of valproate-induced non-convulsive status epilepticus . Seizure . 1993;2:261–265
  90. Lee SA , Lee JK , Heo K . Coma probably induced by lorazepam-valproate interaction . Seizure . 2002;11:124–125
  91. Reiss WG , Oles KS . Acetazolamide in the treatment of seizures . Ann Pharmacother . 1996;30:514–519
  92. Perucca E . Acetazolamide, Sulthiame . In:  Dam M ,  Gram L editor. Comprehensive epileptology . New York: Raven Press; 1991;p. 613–620
  93. Shimizu H , Kawasaki J , Yuasa S , Tarao Y , Kumagai S , Kanemoto K . Use of clobazam for the treatment of refractory complex partial seizures . Seizure . 2003;12:282–286
  94. Genton P , Dravet C . Lennox Gastaut syndrome and other childhood epileptic encephalopathies . In:  Engel J ,  Pedley TA editor. Epilepsy (A comprehensive textbook) . Vol. 3: 1998;p. 2355–2366

PII: S0887-8994(05)00163-3

doi: 10.1016/j.pediatrneurol.2005.03.001

Pediatric Neurology
Volume 33, Issue 4 , Pages 227-234 , October 2005

Article Tools